10th BIC 2019 is joining forces with the 3rd International Conference on Inhibitors for a memorable and exclusive scientific meeting

Mark the new date! Italy, 6-8 September 2019

Sign up now to the free e-mail alert service

Because Italy and Milan will be the site of the ISTH Congress in 2020 chaired by Flora Peyvandi, the Chairs of the Scientific Committee of the 10th BIC International Conference led again by Flora Peyvandi and Pier Mannuccio Mannucci have chosen to hold the 10th BIC in 2019 and combine it with another event focused specifically on factor VIII inhibitors.

We are therefore pleased to announce the Joint meeting of the 10th BIC and the 3rd Inhibitor Conference, which will be held in Italy from 6-8 September 2019.

Both conferences are well recognized around the world as relatively small but exclusive meetings on very specialist topics presented by top international speakers. This joint meeting is meant to take the best of both conferences and feature only the most novel advances of basic science and clinical research in hemophilia, rare inherited coagulation disorders, von Willebrand factor and von Willebrand disease, gene therapy, the thrombotic microangiopathies (TTP, HUS and aHUS) and, of course, factor VIII inhibitors.

The Programme will not only include Scientific Sessions on the aforementioned topics by invited speakers but also freely submitted abstracts presented as oral communications or posters as well as Satellite Symposia sponsored by premier pharmaceutical companies. A new session of the Scientific Programme will focus on the best innovations by the industry in this field.

The major innovations that were presented at the most recent events suggest that 2019 will be a year of continuous development in treatment approaches and new drugs. Data from basic science research and clinical trials are outlining new scenarios, not only in gene therapy but also in the progress of replacement and non-replacement therapies with new drugs appearing in the market.

At the upcoming Joint BIC & Inhibitors Conference, clinical and translational science will be discussed from different angles during a full 3-day programme. The most distinguished experts in the field will present their very latest data and offer their wisdom and insight into the current science developments. Junior and less junior attendees will be able to submit their abstracts and have the chance to present them as oral communications or e-posters. Sponsor companies are invited to showcase their latest findings during their satellite symposia and discuss further developments with a highly competent audience.

To be informed about the detailed programme and location and start networking with the Joint BIC & Inhibitors Conference, please sign up for the free alert service on the website.



P. M. Mannucci


Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

F. Peyvandi


Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy


N. Ciavarella


Former Director of the Hemophilia and Thrombosis Center of the Bari University Hospital. Coordinator of the Technical Panel on Thrombosis of the Apulia Region, Bari, Italy

A. B. Federici


Associate Professor of Hematology at the Department of Internal Medicine, University of Milan and Head of Hematology and Transfusion Medicine at the University Hospital L. Sacco of Milan, Italy

S. Lacroix-Desmazes


Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Centre de Recherche des Cordeliers Paris, France

P.J. Lenting


Inserm U770, Le Kremlin-Bicêtre, France

D. Lillicrap


Department of Pathology and Molecular Medicine, Richardson Laboratory, Queen’s University, Kingston (ON), Canada

J. Voorberg


Department of Plasma Proteins – Sanquin Research and University of Amsterdam, Amsterdam, the Netherlands